Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population
NCT ID: NCT03541954
Last Updated: 2022-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
60 participants
INTERVENTIONAL
2018-07-17
2022-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Effectiveness of PelvicSense(R) on Pain and Sexual Outcomes in Provoked Vestibulodynia
NCT05909514
Implantation of a Pudendal PNA Test Lead for Neuromodulation by the ENTRAMI Technique in Case of Chronic Perineal Pain Syndrome.
NCT03880786
Indirect Non-invasive Evaluation of Pudendal Neuropathy
NCT03933683
Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence
NCT03535857
Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain
NCT03175809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
* 30 patients with chronic pelvic or perineal pain with sensitization (Convergences PP criteria \> 5)
* 30 patients with chronic pelvic or perineal pain without sensitization (Convergences PP criteria \< 5)
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with pelvic or perineal pain with sensitization
Patients with chronic pelvic or perineal pain with sensitization (Convergences PP criteria \> 5)
Sensory testing of lower urinary tract.
Non invasive lower urinary tract sensitivity testing: provoked diuresis with sonographic estimates of sensory thresholds.
Sensory testing of lower rectal tract
Lower digestive tract sensitivity testing: rectal electronic barostat with ascending pressure (phasic distension).
Sensory testing of vulva muscles
Vulvar sensitivity testing: pressure pain threshold evaluated using vulvagesiometer.
Sensory testing of pelvic muscles
Myofascial sensitivity testing: piriformis, levator ani and obturator internus muscles pressure pain threshold evaluated using intra-vaginal algometer.
Patient with pelvic or perineal pain without sensitization
Patients with chronic pelvic or perineal pain without sensitization (Convergences PP criteria \< 5)
Sensory testing of lower urinary tract.
Non invasive lower urinary tract sensitivity testing: provoked diuresis with sonographic estimates of sensory thresholds.
Sensory testing of lower rectal tract
Lower digestive tract sensitivity testing: rectal electronic barostat with ascending pressure (phasic distension).
Sensory testing of vulva muscles
Vulvar sensitivity testing: pressure pain threshold evaluated using vulvagesiometer.
Sensory testing of pelvic muscles
Myofascial sensitivity testing: piriformis, levator ani and obturator internus muscles pressure pain threshold evaluated using intra-vaginal algometer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sensory testing of lower urinary tract.
Non invasive lower urinary tract sensitivity testing: provoked diuresis with sonographic estimates of sensory thresholds.
Sensory testing of lower rectal tract
Lower digestive tract sensitivity testing: rectal electronic barostat with ascending pressure (phasic distension).
Sensory testing of vulva muscles
Vulvar sensitivity testing: pressure pain threshold evaluated using vulvagesiometer.
Sensory testing of pelvic muscles
Myofascial sensitivity testing: piriformis, levator ani and obturator internus muscles pressure pain threshold evaluated using intra-vaginal algometer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pelvic or perineal pain since \> 3 months,
* No injury in pelvic imagery or clinical examination that may explain all the pain complaint,
* Patient who can understand the protocol,
* Patient who agreed and signed the informed consent for participation.
Exclusion Criteria
* Pregnancy or lactation,
* Severe depression (Beck Depression Inventory-Short form \> 16),
* Initial pain estimation at 10 on numeric analog scale,
* Inadequately cooperating,
* Isolated dysmenorrhea,
* Deep endometriosis with rectal or bladder lesion,
* Genital or bladder infection,
* Urogenital tumor history,
* Anorectal surgery history a type of digestive resection,
* Anal stenosis,
* Advanced vaginal prolapse (stage 2 on POP-Q scale),
* Post-traumatic stress disorder history,
* Deprived of liberty (trusteeship, guardianship).
25 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes university Hospital
Nantes, , France
Groupe Confluent
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cardaillac C, Levesque A, Riant T, Mortier A, Neunlist M, Perrouin-Verbe MA, Volteau C, Thubert T, Brochard C, Ploteau S. Evaluation of a scoring system for the detection of central sensitization among women with chronic pelvic pain. Am J Obstet Gynecol. 2023 Nov;229(5):530.e1-530.e17. doi: 10.1016/j.ajog.2023.07.044. Epub 2023 Jul 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC17_0427
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.